0001127602-14-006904.txt : 20140218 0001127602-14-006904.hdr.sgml : 20140217 20140218201214 ACCESSION NUMBER: 0001127602-14-006904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140213 FILED AS OF DATE: 20140218 DATE AS OF CHANGE: 20140218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E CENTRAL INDEX KEY: 0001222679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 14623705 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-02-13 0001022079 QUEST DIAGNOSTICS INC DGX 0001222679 PREVOZNIK MICHAEL E C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & General Counsel Common Stock 2014-02-13 4 A 0 4985 0 A 50291 D Common Stock 2014-02-18 4 F 0 1737 52.555 D 48622 D Common Stock 4526 I 401k/SDCP Stock Options (Right to Buy) 52.165 2014-02-13 4 A 0 47454 0 A 2024-02-13 Common Stock 47454 47454 D Represents an award of restricted share units. Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. The amount includes approximately 29 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan. The information was obtain from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik 2014-02-18